Novavax, Inc. (NVAX)

Novavax (NVAX) Increases Despite Market Slip: Here's What You Need to Know

Vaccine Stocks Rally on Reports of U.S.-led Push for Cancer Vaccines

Novavax Soars 16%, Moderna Surges 11%, Merck Climbs 3% as Biotech Rallies

Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know

Novavax (NASDAQ:NVAX) Stock Jumps 10.5% – Should You Buy?

Novavax (NVAX) Stock Sinks As Market Gains: Here's Why

Novavax Stock Falls Back: What's Going On?

Novavax Pulls Back From Plague-Scare Spike as Officials Call Risk Low; Moderna Nudges Higher, Pfizer Inches Higher

Novavax (NVAX) Surges 20.1%: Is This an Indication of Further Gains?

Novavax Shorts on Edge as Russia Plague Fears Spread

Novavax Soars 22% as Sanofi Carries Nuvaxovid Into Vaccination Season; Moderna Climbs 8%, BioNTech Ticks Up

Novavax (NVAX) Rises As Market Takes a Dip: Key Facts

Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It

Novavax (NVAX) Beats Stock Market Upswing: What Investors Need to Know

Novavax (NVAX) Soars 7.0%: Is Further Upside Left in the Stock?

Moderna Climbs 6% as Cancer Vaccine Trade Extends a 137% Month; BioNTech and Novavax Edge Higher

Investors Heavily Search Novavax, Inc. (NVAX): Here is What You Need to Know

Novavax (NVAX) Laps the Stock Market: Here's Why

Novavax Highlights Sanofi, Pfizer Catalysts in Matrix-M Platform Pivot

Novavax, Inc. (NVAX) Presents at Citigroup's Biopharma Back to School Summit 2026 Transcript